We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+2.94%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.5B
AUM Growth
-$26.3M
Cap. Flow
-$36.9M
Cap. Flow %
-0.82%
Top 10 Hldgs %
8.67%
Holding
752
New
65
Increased
220
Reduced
377
Closed
83

Top Buys

Rank Stock Value
1
BOOT icon
Boot Barn
BOOT
+$17.2M
2
UPBD icon
Upbound Group
UPBD
+$10.9M
3
MRCY icon
Mercury Systems
MRCY
+$10.6M
4
KMPR icon
Kemper
KMPR
+$9.56M
5
ESAB icon
ESAB
ESAB
+$8.84M

Sector Composition

Rank Sector Weight
1 Financials 20.83%
2 Industrials 18.44%
3 Healthcare 17.49%
4 Technology 13.76%
5 Consumer Discretionary 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSPN icon
376
OneSpan
OSPN
$603M
$3.82M 0.08%
205,838
-53,805
-21% -$915K
WNC icon
377
Wabash National
WNC
$510M
$3.79M 0.08%
221,189
-136,042
-38% -$2.52M
ACLS icon
378
Axcelis
ACLS
$4.1B
$3.76M 0.08%
53,881
-33,033
-38% -$2.74M
BROS icon
379
Dutch Bros
BROS
$8.96B
$3.75M 0.08%
71,598
-257
-0.4% -$11.3K
NPO icon
380
Enpro
NPO
$7.04B
$3.74M 0.08%
21,697
-30,432
-58% -$5.14M
PEP icon
381
PepsiCo
PEP
$188B
$3.71M 0.08%
24,423
REGN icon
382
Regeneron Pharmaceuticals
REGN
$83.2B
$3.67M 0.08%
5,156
+652
+14% +$547K
SLAB icon
383
Silicon Laboratories
SLAB
$7.2B
$3.67M 0.08%
29,524
+2,060
+8% +$236K
AGIO icon
384
Agios Pharmaceuticals
AGIO
$1.95B
$3.65M 0.08%
111,098
+81,971
+281% +$3.85M
ACCD
385
DELISTED
Accolade Inc
ACCD
$3.64M 0.08%
1,065,757
+309,201
+41% +$1.1M
CUZ icon
386
Cousins Properties
CUZ
$4.83B
$3.64M 0.08%
118,746
-17,113
-13% -$525K
ICFI icon
387
ICF International
ICFI
$1.64B
$3.64M 0.08%
30,515
-22,933
-43% -$3.43M
BMRC icon
388
Bank of Marin Bancorp
BMRC
$455M
$3.62M 0.08%
152,267
+35,958
+31% +$849K
AZN icon
389
AstraZeneca
AZN
$251B
$3.61M 0.08%
27,544
+17,989
+188% +$2.52M
EQBK icon
390
Equity Bancshares
EQBK
$1.04B
$3.59M 0.08%
+84,712
New +$3.77M
SRPT icon
391
Sarepta Therapeutics
SRPT
$1.81B
$3.58M 0.08%
29,457
+3,776
+15% +$463K
COGT icon
392
Cogent Biosciences
COGT
$7.1B
$3.56M 0.08%
457,048
-5,140
-1% -$51.2K
ALGM icon
393
Allegro MicroSystems
ALGM
$7.91B
$3.56M 0.08%
162,766
-64,469
-28% -$1.37M
CMP icon
394
Compass Minerals
CMP
$1.13B
$3.53M 0.08%
+314,066
New +$4.1M
SYK icon
395
Stryker
SYK
$133B
$3.51M 0.08%
9,753
+5,251
+117% +$1.95M
HE icon
396
Hawaiian Electric Industries
HE
$2.02B
$3.46M 0.08%
+355,551
New +$3.59M
DEI icon
397
Douglas Emmett
DEI
$1.93B
$3.45M 0.08%
185,777
-10,656
-5% -$199K
PLMR icon
398
Palomar
PLMR
$3.46B
$3.44M 0.08%
32,571
-5,463
-14% -$554K
VECO icon
399
Veeco
VECO
$3.02B
$3.44M 0.08%
128,249
+55,624
+77% +$1.61M
ST icon
400
Sensata Technologies
ST
$6.66B
$3.41M 0.08%
124,592
-7,056
-5% -$229K

Similar funds

Kennedy Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Kennedy Capital Management held 752 positions worth $4.5B, down 0.58% from $4.53B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Kennedy Capital Management's Q4 2024 filing shows 65 new, 220 increased, 377 reduced and 83 closed positions. Its largest new stake was Boot Barn: 116,357 shares worth $17.7M. The largest sale was Stifel, an estimated $19.5M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

  • Kennedy Capital Management's largest Q4 2024 buy was Boot Barn: 116,357 shares worth $17.7M.
  • Kennedy Capital Management added most to Mercury Systems in Q4 2024, an estimated $10.6M increase.
  • Kennedy Capital Management's biggest Q4 2024 reduction was Stifel, cutting an estimated $19.5M.
  • Kennedy Capital Management fully exited Phathom Pharmaceuticals in Q4 2024, selling an estimated $13.2M.
  • Kennedy Capital Management's ten largest holdings make up 8.7% of its $4.5B portfolio in Q4 2024.
  • Kennedy Capital Management opened 65 new positions and closed 83 in Q4 2024.
  • Kennedy Capital Management's portfolio value fell 0.58% quarter-over-quarter to $4.5B.

Based on Kennedy Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.